Sources | Names Used |
---|---|
CTRPv2 | selumetinib:BRD-A02303741 (4:1 mol/mol) |
PharmacoGx | selumetinib:BRD-A02303741 (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BLM | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
mRNA | MLANA | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | TTYH2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | MYL6B | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | SSRP1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | UBAC2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | SLC9B2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
mRNA | AMT | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | HTATSF1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | MALT1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |